Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.-Reference-Cited by-同舟云学术

Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.

Published:1991-06 Issue:6 Volume:31 Page:635-642
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Yue QY,Hasselstrom J.,Svensson JO,Sawe J.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1991.tb05585.x/fullpdf

Reference40 articles.

1. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats;Abbott;Life Sci.,1988

2. Plasma level and renal excretion of [3H] codeine phosphate in man and in the dog;Bechtel;Arzneim.-Forsch.,1978

3. Oral administration of codeine in the presence of ethanol: a pharmacokinetic study in man;Bodd;Pharmac. Tox.,1987

4. Clinical significance of the sparteine/debrisoquine oxidation polymorphism;Brøsen;Eur. J. clin. Pharmac.,1989

5. Polymorphic O-demethylation of codeine;Chen;Lancet,1988

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic modeling to predict the pharmacokinetics of codeine in different CYP2D6 phenotypes;Frontiers in Pharmacology;2024-05-02

2. Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions;Journal of Pharmacology and Experimental Therapeutics;2023-09-07

3. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

4. Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT1A) Receptors Heterodimerization and Cellular Effectors (Ca2+, ERK1/2 and p38) Activation;Molecules;2022-04-06

5. Consensus multidisciplinaire de l’intergroupe SFETD/SFGG sur l’utilisation des opioïdes dits faibles dans la prise en charge de la douleur chez la personne âgée;Douleur et Analgésie;2021-12